Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone replacement therapy versus mild ovarian stimulation for endometrial preparation in frozen embryo transfer in women with polycystic ovary syndrome
IRCT20130603013566N14Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2024
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of estradiol, progesterone, letrozole, follicle-stimulating hormone and human chorionic gonadotropin in female infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Successful pregnancy. Started Oct 2024; status: completed.
02
Drugs
estradiolprogesteroneletrozolefollicle-stimulating hormonehuman chorionic gonadotropin
03
Conditions
female infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20130603013566N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130603013566N14.